ARCHIVES

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

This article is from The Cancer Letter archive.

Vol. 09 No. 15 | April 15, 1983

Download PDF Visit The Full Archive

Related Articles

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says

March 28, 2003

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

NCI-Approved Protocols Listed

March 28, 2003